Surgify Medical, an Espoo-based MedTech firm targeted on bettering the protection and precision of bone surgical procedure with its Surgify Halo expertise, has efficiently raised €7 million in Collection A funding.
The funding spherical was led by ZEISS Ventures, the company enterprise arm of the Carl Zeiss Group, with participation from the European Innovation Council Fund (EIC Fund). Surgify’s current buyers, together with Lednil and Cascara Ventures, additionally participated within the financing.
“ZEISS brings unparalleled expertise in surgical expertise and a world community, whereas the EIC’s continued assist and earlier grant financing underscore the European innovation ecosystem’s confidence in our resolution,” stated Visa Sippola, Co-founder and CEO of Surgify Medical. “With this funding and regulatory approvals in each the EU and the U.S., we’re well-positioned to deliver our distinctive expertise to extra surgeons and sufferers internationally.”
Based in 2017, Surgify Medical is devoted to innovating bone surgical procedure by making it safer, quicker, and extra exact. The corporate’s flagship product, Surgify Halo, is designed to distinguish between arduous and tender tissues, reportedly offering enhanced safety towards incidental tender tissue harm and streamlining procedures.
The advantages of Surgify Halo prolong past its core market of head, neck, and backbone surgical procedures. Surgify’s expertise additionally has the potential to influence the rising area of robotic surgical procedure by enabling dependable automated bone resection.
With the funding, the corporate plans to take the subsequent steps towards changing into a number one provider within the multi-billion-euro marketplace for bone surgical procedure gadgets. Constructing on a profitable Nordic market launch, the corporate will develop its operations within the EU and the US, the place Surgify says key hospitals have already began adopting the expertise.
“Surgify’s expertise is a significant breakthrough in as we speak’s evolving healthcare panorama. With over a thousand affected person procedures, Surgify Halo has already left a major footprint within the area. The corporate goals to guard sufferers, save prices, and has already achieved groundbreaking developments in robotic surgical procedure functions,” stated Alan Raffensperger, Chairman of Surgify Medical.
In keeping with the corporate, standard surgical drills spin tens of 1000’s of instances per minute and may be harmful if they arrive into contact with essential tender tissue. At worst, such tender tissue harm can lead to extreme damage to the affected person. Delicate tissue accidents are thought of a extremely related surgical complication in lots of forms of head, neck, and backbone procedures involving bone resection and end in over €4 billion in annual complication-related prices globally.
Surgify Halo reportedly cuts bone whereas offering distinctive protecting capabilities towards incidental accidents to tender tissues corresponding to central nervous system buildings, blood vessels, and nerves. The expertise is alleged to offer efficient bone resection together with a tender tissue safety function for enhanced security and precision in surgical procedures.
“We’re excited to accomplice with Surgify of their mission to ascertain a brand new benchmark for surgical security. Surgify’s Halo burrs provide distinctive management at slicing charges similar to conventional burrs, whereas concurrently safeguarding delicate tender tissues. This makes the change to Halo burrs an apparent selection for surgeons,” explains Dr Boris Hofmann, Head of ZEISS Ventures. “We’re wanting to assist the workforce as they develop their resolution on a world scale.”
Thus far, Surgify Medical has raised €14 million in whole funding and has places of work in Finland, Sweden, Denmark and the US.
